Showing results (121-130 of 187) with videos related to

Sort By:
Pageof 19
Clinical Neuropharmacology|June 1, 1993
Quantitative electromyographic analysis of changes in muscle activity following botulinum toxin therapy for cervical dystoniaA S Buchman, C L Comella, G T Stebbins, et al.
Neurology|August 1, 1989
Agonist substitution in advanced Parkinson's diseaseC G Goetz, K M Shannon, C M Tanner, et al.
Neurology|May 1, 1987
Parkinson's disease and motor fluctuations: long-acting carbidopa/levodopa (CR-4-Sinemet)C G Goetz, C M Tanner, H L Klawans, et al.
Brain and Cognition|April 8, 2000
Impaired frontostriatal cognitive functioning following posteroventral pallidotomy in advanced Parkinson's diseaseG T Stebbins, J D Gabrieli, K M Shannon, et al.
Clinical Neuropharmacology|December 1, 1987
Amantadine and motor fluctuations in chronic Parkinson's diseaseK M Shannon, C G Goetz, V S Carroll, et al.
Neurology|December 31, 1997
Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating ScaleD A Bennett, K M Shannon, L A Beckett, et al.
Clinical Neuropharmacology|October 28, 1998
Poor visual discrimination and visual hallucinations in Parkinson's diseaseN J Diederich, C G Goetz, R Raman, et al.
European Journal of Pharmacology|January 21, 1986
The effect of antimuscarinic agents on haloperidol induced behavioral hypersensitivityP M Carvey, L C Kao, C M Tanner, et al.
Neurology|October 1, 1982
Pergolide mesylate and idiopathic Parkinson diseaseC M Tanner, C G Goetz, R H Glantz, et al.
Neurology|April 1, 1992
Botulinum toxin injection for spasmodic torticollis: increased magnitude of benefit with electromyographic assistanceC L Comella, A S Buchman, C M Tanner, et al.
Pageof 19